Extedo Customer Base Expands Into the Chinese Market

Extedo, a key eRegulatory Affairs solutions provider for life sciences firms, has announced that Beijing Second Pharmaceutical Co, Ltd (BSPC), one of China’s leading pharmaceutical companies, has selected the eCTDmanager Suite™ to manage regulatory submissions. The Extedo eCTDmanager Suite provides Beijing Second Pharmaceutical with an easy-to-use electronic management solution for building, viewing, validating, and publishing compliant submissions that meet global regulatory specifications. "Since we will distribute our products to USA, EU and other outside markets, we need a flexible submission management solution," said Wenfeng Wang, Vice General Manager of Research and Development for Beijing Second Pharma. "One important reason why we selected Extedo was that their solution enables us to easily submit NDAs, eNDAs, eCTD and hybrid submissions with a single tool.""This is a very significant customer win for us," stated Martin Schmid, Managing Director of Extedo. "With Beijing Second Pharma, Extedo has entered an emerging Life Science market that is growing quickly. This project confirms our global growth strategy and will enable us to close additional business in the APAC region."